An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome

Toru Udaka, Nobuhiko Okamoto, Michihiko Aramaki, Chiharu Torii, Rika Kosaki, Noboru Hosokai, Toshiyuki Hayakawa, Naoyuki Takahata, Takao Takahashi, Kenjiro Kosaki

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

CHD7 mutations account for about 60-65% among more than 200 CHARGE syndrome cases. When rare whole gene deletion cases associated with chromosomal abnormalities are excluded, all mutations of CHD7 reported to date have been point mutations and small deletions and insertions, rather than exonic deletions. To test whether exonic deletions represent a common pathogenic mechanism, we assessed exon copy number by using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). Multiple exons were amplified using unlabeled primers, then separated by ion-pair reversed-phase high-performance liquid chromatography, and quantitated by fluorescence detection using a post-column intercalation dye under the premise that the relative peak intensities for each target directly reflect exon copy number. By using MP/LC, we identified one CHARGE syndrome patient who had a de novo deletion encompassing exons 8-12 among 13 classic CHARGE patients in whom screening by denaturing high-performance liquid chromatography (DHPLC) failed to identify point mutations and small insertions/deletions in CHD7. This is the first CHARGE patient who was documented to have exonic deletion of CHD7. The deletion closely recapitulated the Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid hydroxylase gene (CMP-Neu5Ac hydroxylase), which is regarded as a novel molecular mechanism in the evolution from non-human primates to humans. As demonstrated in this study, MP/LC is a promising method for characterizing exonic deletions, which are largely left unexamined in most routine mutation analysis.

Original languageEnglish
Pages (from-to)721-726
Number of pages6
JournalAmerican Journal of Medical Genetics, Part A
Volume143
Issue number7
DOIs
Publication statusPublished - 2007 Apr 1

Fingerprint

CHARGE Syndrome
Exons
Multiplex Polymerase Chain Reaction
Liquid Chromatography
Point Mutation
Mutation
High Pressure Liquid Chromatography
Gene Deletion
Reverse-Phase Chromatography
Chromosome Aberrations
Primates
Coloring Agents
Fluorescence
Ions
Genes

Keywords

  • CHARGE syndrome
  • DHPLC
  • Quantitative PCR
  • Rearrangement

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome. / Udaka, Toru; Okamoto, Nobuhiko; Aramaki, Michihiko; Torii, Chiharu; Kosaki, Rika; Hosokai, Noboru; Hayakawa, Toshiyuki; Takahata, Naoyuki; Takahashi, Takao; Kosaki, Kenjiro.

In: American Journal of Medical Genetics, Part A, Vol. 143, No. 7, 01.04.2007, p. 721-726.

Research output: Contribution to journalArticle

Udaka, T, Okamoto, N, Aramaki, M, Torii, C, Kosaki, R, Hosokai, N, Hayakawa, T, Takahata, N, Takahashi, T & Kosaki, K 2007, 'An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome', American Journal of Medical Genetics, Part A, vol. 143, no. 7, pp. 721-726. https://doi.org/10.1002/ajmg.a.31441
Udaka, Toru ; Okamoto, Nobuhiko ; Aramaki, Michihiko ; Torii, Chiharu ; Kosaki, Rika ; Hosokai, Noboru ; Hayakawa, Toshiyuki ; Takahata, Naoyuki ; Takahashi, Takao ; Kosaki, Kenjiro. / An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome. In: American Journal of Medical Genetics, Part A. 2007 ; Vol. 143, No. 7. pp. 721-726.
@article{8a02909fd51547fd8b44ff6da94f8f44,
title = "An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome",
abstract = "CHD7 mutations account for about 60-65{\%} among more than 200 CHARGE syndrome cases. When rare whole gene deletion cases associated with chromosomal abnormalities are excluded, all mutations of CHD7 reported to date have been point mutations and small deletions and insertions, rather than exonic deletions. To test whether exonic deletions represent a common pathogenic mechanism, we assessed exon copy number by using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). Multiple exons were amplified using unlabeled primers, then separated by ion-pair reversed-phase high-performance liquid chromatography, and quantitated by fluorescence detection using a post-column intercalation dye under the premise that the relative peak intensities for each target directly reflect exon copy number. By using MP/LC, we identified one CHARGE syndrome patient who had a de novo deletion encompassing exons 8-12 among 13 classic CHARGE patients in whom screening by denaturing high-performance liquid chromatography (DHPLC) failed to identify point mutations and small insertions/deletions in CHD7. This is the first CHARGE patient who was documented to have exonic deletion of CHD7. The deletion closely recapitulated the Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid hydroxylase gene (CMP-Neu5Ac hydroxylase), which is regarded as a novel molecular mechanism in the evolution from non-human primates to humans. As demonstrated in this study, MP/LC is a promising method for characterizing exonic deletions, which are largely left unexamined in most routine mutation analysis.",
keywords = "CHARGE syndrome, DHPLC, Quantitative PCR, Rearrangement",
author = "Toru Udaka and Nobuhiko Okamoto and Michihiko Aramaki and Chiharu Torii and Rika Kosaki and Noboru Hosokai and Toshiyuki Hayakawa and Naoyuki Takahata and Takao Takahashi and Kenjiro Kosaki",
year = "2007",
month = "4",
day = "1",
doi = "10.1002/ajmg.a.31441",
language = "English",
volume = "143",
pages = "721--726",
journal = "American Journal of Medical Genetics",
issn = "1552-4868",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - An Alu retrotransposition-mediated deletion of CHD7 in a patient with CHARGE syndrome

AU - Udaka, Toru

AU - Okamoto, Nobuhiko

AU - Aramaki, Michihiko

AU - Torii, Chiharu

AU - Kosaki, Rika

AU - Hosokai, Noboru

AU - Hayakawa, Toshiyuki

AU - Takahata, Naoyuki

AU - Takahashi, Takao

AU - Kosaki, Kenjiro

PY - 2007/4/1

Y1 - 2007/4/1

N2 - CHD7 mutations account for about 60-65% among more than 200 CHARGE syndrome cases. When rare whole gene deletion cases associated with chromosomal abnormalities are excluded, all mutations of CHD7 reported to date have been point mutations and small deletions and insertions, rather than exonic deletions. To test whether exonic deletions represent a common pathogenic mechanism, we assessed exon copy number by using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). Multiple exons were amplified using unlabeled primers, then separated by ion-pair reversed-phase high-performance liquid chromatography, and quantitated by fluorescence detection using a post-column intercalation dye under the premise that the relative peak intensities for each target directly reflect exon copy number. By using MP/LC, we identified one CHARGE syndrome patient who had a de novo deletion encompassing exons 8-12 among 13 classic CHARGE patients in whom screening by denaturing high-performance liquid chromatography (DHPLC) failed to identify point mutations and small insertions/deletions in CHD7. This is the first CHARGE patient who was documented to have exonic deletion of CHD7. The deletion closely recapitulated the Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid hydroxylase gene (CMP-Neu5Ac hydroxylase), which is regarded as a novel molecular mechanism in the evolution from non-human primates to humans. As demonstrated in this study, MP/LC is a promising method for characterizing exonic deletions, which are largely left unexamined in most routine mutation analysis.

AB - CHD7 mutations account for about 60-65% among more than 200 CHARGE syndrome cases. When rare whole gene deletion cases associated with chromosomal abnormalities are excluded, all mutations of CHD7 reported to date have been point mutations and small deletions and insertions, rather than exonic deletions. To test whether exonic deletions represent a common pathogenic mechanism, we assessed exon copy number by using a recently developed method, the multiplex PCR/liquid chromatography assay (MP/LC). Multiple exons were amplified using unlabeled primers, then separated by ion-pair reversed-phase high-performance liquid chromatography, and quantitated by fluorescence detection using a post-column intercalation dye under the premise that the relative peak intensities for each target directly reflect exon copy number. By using MP/LC, we identified one CHARGE syndrome patient who had a de novo deletion encompassing exons 8-12 among 13 classic CHARGE patients in whom screening by denaturing high-performance liquid chromatography (DHPLC) failed to identify point mutations and small insertions/deletions in CHD7. This is the first CHARGE patient who was documented to have exonic deletion of CHD7. The deletion closely recapitulated the Alu-mediated inactivation of the human CMP-N-acetylneuraminic acid hydroxylase gene (CMP-Neu5Ac hydroxylase), which is regarded as a novel molecular mechanism in the evolution from non-human primates to humans. As demonstrated in this study, MP/LC is a promising method for characterizing exonic deletions, which are largely left unexamined in most routine mutation analysis.

KW - CHARGE syndrome

KW - DHPLC

KW - Quantitative PCR

KW - Rearrangement

UR - http://www.scopus.com/inward/record.url?scp=34247215966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247215966&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.31441

DO - 10.1002/ajmg.a.31441

M3 - Article

C2 - 17334995

AN - SCOPUS:34247215966

VL - 143

SP - 721

EP - 726

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4868

IS - 7

ER -